Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register account icon
S&P 500
7,611.18
(
0.15%
)
US TECH 100
29,817.20
(
0.36%
)
Dow Jones
51,325.28
(
0.48%
)
Brent Oil
95.50
(
-0.49%
)
Bitcoin
67,208.93
(
-5.83%
)
News Focus
News Focus
Post# of 519090
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

georgejjl

Send PM Follow Ignore
Followers 148
Posts 26302
Boards Moderated 0
Alias Born 04/08/2004

georgejjl

Re: gerry57 post# 493960

Wednesday, 07/16/2025 11:33:03 AM

Wednesday, July 16, 2025 11:33:03 AM

Post# of 519090
Sigma - 1 receptor activation as a new option for the treatment of glaucoma in preclinical models

https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1755-3768.2022.15344

Anavex’s blarcamesine and/or Anavex 3-71 can be taken to treat and/or prevent glaucoma,

Good luck and GOD bless,
Bullish
Bullish
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News